A detailed history of Global Retirement Partners, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Global Retirement Partners, LLC holds 16 shares of NKTR stock, worth $18. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 16 -0.0%
Holding current value
$18
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

BUY
$0.64 - $3.15 $10 - $50
16 New
16 $0
Q2 2022

Jul 15, 2022

SELL
$3.17 - $6.17 $1,416 - $2,757
-447 Reduced 83.55%
88 $0
Q1 2022

Jul 14, 2022

BUY
$4.16 - $13.72 $2,225 - $7,340
535 New
535 $2,000
Q2 2021

Jul 15, 2021

SELL
$16.52 - $20.4 $4,956 - $6,120
-300 Closed
0 $0
Q2 2020

Jul 13, 2020

BUY
$16.86 - $23.44 $5,058 - $7,032
300 New
300 $7,000
Q3 2017

Aug 10, 2018

SELL
$17.79 - $24.0 $3,024 - $4,080
-170 Closed
0 $0
Q4 2016

Aug 10, 2018

BUY
N/A
170
170 $2,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $219M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.